{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:08:07Z","timestamp":1777075687277,"version":"3.51.4"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Doxazosin (DOX) is prescribed as a racemic drug for the clinical treatment of benign prostatic hyperplasia and hypertension. Recent studies found that the two enantiomers of DOX exhibit differences in blood concentration and pharmacological effects. However, the stereoselective metabolic characteristics and mechanisms for DOX are not yet clear. Herein, we identified 34 metabolites of DOX in rats based on our comprehensive and effective strategy. The relationship among the metabolites and the most discriminative metabolites between (\u2212)-DOX and (+)-DOX administration was analyzed according to the kinetic parameters using state-of-the-art multivariate statistical methods. To elucidate the enantioselective metabolic profile <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>, we carefully investigated the metabolic characteristics of metabolites after optically pure isomers administration in rat plasma, rat liver microsomes (RLMs) or human liver microsomes (HLMs), and recombinant human cytochrome P450 (CYP) enzymes. As a result, the differences of these metabolites were found based on their exposure and elimination rate, and the metabolic profile of (\u00b1)-DOX was more similar to that of (+)-DOX. Though the metabolites identified in RLMs and HLMs were the same, the metabolic profiles of the metabolites from (\u2212)-DOX and (+)-DOX were greatly different. Furthermore, four human CYP enzymes could catalyze DOX to produce metabolites, but their preferences seemed different. For example, CYP3A4 highly specifically and selectively catalyzed the formation of the specific metabolite (M22) from (\u2212)-DOX. In conclusion, we established a comprehensive metabolic system using pure optical isomers from <jats:italic>in vivo<\/jats:italic> to <jats:italic>in vitro<\/jats:italic>, and the complicated enantioselectivity of the metabolites of DOX was clearly shown. More importantly, the comprehensive metabolic system is also suitable to investigate other chiral drugs.<\/jats:p>","DOI":"10.3389\/fphar.2022.834897","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:56:46Z","timestamp":1646917006000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Elucidating a Complicated Enantioselective Metabolic Profile: A Study From Rats to Humans Using Optically Pure Doxazosin"],"prefix":"10.3389","volume":"13","author":[{"given":"Dezhi","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunfeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panpan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiming","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1111\/j.1476-5381.2011.01649_9.x","article-title":"Enzymes","volume":"164","author":"Alexander","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1208\/s12248-016-9962-6","article-title":"Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance","volume":"18","author":"Argikar","year":"2016","journal-title":"AAPS J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","article-title":"Impact of Obesity on Drug Metabolism and Elimination in Adults and Children","volume":"51","author":"Brill","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"140131","DOI":"10.1016\/j.scitotenv.2020.140131","article-title":"Photolytic and Photocatalytic Degradation of Doxazosin in Aqueous Solution","volume":"740","author":"Bujak","year":"2020","journal-title":"Sci. Total Environ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.12659\/msm.896283","article-title":"A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia","volume":"22","author":"Cao","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"B6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/rcm.7789","article-title":"Performance Comparison of Electrospray Ionization and Atmospheric Pressure Chemical Ionization in Untargeted and Targeted Liquid Chromatography\/mass Spectrometry Based Metabolomics Analysis of Grapeberry Metabolites","volume":"31","author":"Commisso","year":"2017","journal-title":"Rapid Commun. Mass. Spectrom."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.16438\/j.0513-4870.2016-0015","article-title":"Quantification of (-)doxazosin at Very Low Concentration in Rat Plasma Samples by SPE-LC-MS\/MS","volume":"51","author":"Du","year":"2016","journal-title":"Yao Xue Xue Bao"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.eururo.2015.12.034","article-title":"\u03b11-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis of Urodynamic Studies","volume":"69","author":"Fusco","year":"2016","journal-title":"Eur. Urol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s13361-014-1064-z","article-title":"Stable Isotope Labeling Strategy for Curcumin Metabolite Study in Human Liver Microsomes by Liquid Chromatography-Tandem Mass Spectrometry","volume":"26","author":"Gao","year":"2015","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"B10","doi-asserted-by":"publisher","first-page":"10964","DOI":"10.1021\/acscatal.8b03401","article-title":"Mechanisms of Cytochrome P450-Catalyzed Oxidations","volume":"8","author":"Guengerich","year":"2018","journal-title":"ACS Catal."},{"key":"B11","doi-asserted-by":"publisher","first-page":"461679","DOI":"10.1016\/j.chroma.2020.461679","article-title":"Derivatization-based Sample-Multiplexing for Enhancing Throughput in Liquid Chromatography\/tandem Mass Spectrometry Quantification of Metabolites: an Overview","volume":"1634","author":"Higashi","year":"2020","journal-title":"J. Chromatogr. A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3168\/jds.2019-17277","article-title":"Target Analysis and Retrospective Screening of Mycotoxins and Pharmacologically Active Substances in Milk Using an Ultra-high-performance Liquid Chromatography\/high-Resolution Mass Spectrometry Approach","volume":"103","author":"Izzo","year":"2020","journal-title":"J. Dairy Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/22297928.2019.1633953","article-title":"A Rapid and Sensitive Reversed Phase Liquid Chromatography-Tandem Mass Spectrometry Method for Quantification of Doxazosin Mesylate in Human Plasma Using Doxazosin Mesylate D8 as Internal Standard","volume":"9","author":"Kapri","year":"2019","journal-title":"Anal. Chem. Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e22905","DOI":"10.1002\/jbt.22905","article-title":"Doxazosin and Erlotinib Have Anticancer Effects in the Endometrial Cancer Cell and Important Roles in ER\u03b1 and Wnt\/\u03b2\u2010catenin Signaling Pathways","volume":"35","author":"Karaca","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"19S","DOI":"10.1111\/j.1365-2125.1986.tb02849.x","article-title":"The Metabolism and Kinetics of Doxazosin in Man, Mouse, Rat and Dog","volume":"21","author":"Kaye","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1179546819845883","DOI":"10.1177\/1179546819845883","article-title":"The Effect of Genetically Guided Mathematical Prediction and the Blood Pressure Response to Pharmacotherapy in Hypertension Patients","volume":"13","author":"Kelley","year":"2019","journal-title":"Clin. Med. Insights Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jchromb.2017.11.009","article-title":"Non-targeted Metabolomics-Guided Sildenafil Metabolism Study in Human Liver Microsomes","volume":"1072","author":"Kim","year":"2018","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jpba.2015.11.023","article-title":"In Vitro metabolism of a Novel Synthetic Cannabinoid, EAM-2201, in Human Liver Microsomes and Human Recombinant Cytochrome P450s","volume":"119","author":"Kim","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejps.2015.06.022","article-title":"The Truth about the Lower Plasma Concentration of the (-)-isomer after Racemic Doxazosin Administration in Rats: Stereoselective Inhibition of the (-)-isomer by the (+)-isomer at CYP3A","volume":"77","author":"Kong","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2125.2006.02796.x","article-title":"The Influence of CYP2D6 Phenotype on the Clinical Response of Nebivolol in Patients with Essential Hypertension","volume":"63","author":"Lefebvre","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/chir.22483","article-title":"Enantioselective Pharmacokinetics of Doxazosin and Pharmacokinetic Interaction between the Isomers in Rats","volume":"27","author":"Li","year":"2015","journal-title":"Chirality"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.jchromb.2010.07.027","article-title":"Enantioselective Determination of Doxazosin in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry Using Ovomucoid Chiral Stationary Phase","volume":"878","author":"Liu","year":"2010","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1021\/jf404784q","article-title":"Identification of Plant Metabolites of Environmental Contaminants by UPLC-QToF-MS: the In Vitro Metabolism of Triclosan in Horseradish","volume":"62","author":"Macherius","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/cpt.1538","article-title":"Emerging Applications of Metabolomics in Clinical Pharmacology","volume":"106","author":"Pang","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1871527317666181029111739","article-title":"Differential Effects of Doxazosin on Renin-Angiotensin-System- Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells","volume":"18","author":"Ram\u00edrez-Exp\u00f3sito","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets."},{"key":"B26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/FTD.0000000000000707","article-title":"A Reversed-phase Mode LC-MS\/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation","volume":"42","author":"Suzuki","year":"2020","journal-title":"Ther. Drug Monit."},{"key":"B27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/biomedicines8080273","article-title":"Doxazosin, a Classic Alpha 1-adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug Repurposing","volume":"8","author":"Suzuki","year":"2020","journal-title":"Biomedicines"},{"key":"B28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ejps.2017.04.014","article-title":"Novel sulphur-containing Imatinib Metabolites Found by Untargeted LC-HRMS Analysis","volume":"104","author":"Vrobel","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"B29","first-page":"46","article-title":"Impact of \u03b1-adrenoceptor Antagonists on Prostate Cancer Development, Progression and Prevention","volume":"7","author":"Wade","year":"2019","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus Placebo, Bisoprolol, and Doxazosin to Determine the Optimal Treatment for Drug-Resistant Hypertension (PATHWAY-2): a Randomised, Double-Blind, Crossover Trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11813","DOI":"10.1039\/C7RA13760E","article-title":"Identification of Metabolites of Liquiritin in Rats by UHPLC-Q-TOF-MS\/MS: Metabolic Profiling and Pathway Comparisonin Vitroandin Vivo","volume":"8","author":"Zhang","year":"2018","journal-title":"RSC Adv."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1139\/y2012-129","article-title":"Chiral Recognition of Doxazosin Enantiomers in 3 Targets for Therapy as Well as Adverse Drug Reactions in Animal Experiments","volume":"90","author":"Zhao","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.ijleo.2011.10.005","article-title":"Determination of Doxazosin Enantiomers in Rat Plasma and Investigation of Their Chiral Inversion","volume":"48","author":"Zhen","year":"2013","journal-title":"Yao Xue Xue Bao"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.834897\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:56:55Z","timestamp":1646917015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.834897\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":33,"alternative-id":["10.3389\/fphar.2022.834897"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.834897","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"article-number":"834897"}}